Cargando…

Myeloma natural killer cells are exhausted and have impaired regulation of activation

Detalles Bibliográficos
Autores principales:	D’Souza, Criselle, Keam, Simon P., Yeang, Han Xian Aw, Neeson, Michael, Richardson, Kelden, Hsu, Andy K., Canfield, Rachael, Bezman, Natalie, Robbins, Michael, Quach, Hang, Ritchie, David S., Harrison, Simon J., Trapani, Joseph A., Prince, H. Miles, Beavis, Paul A., Darcy, Phillip K., Neeson, Paul J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8409027/ https://www.ncbi.nlm.nih.gov/pubmed/34011135 http://dx.doi.org/10.3324/haematol.2020.277525

Ejemplares similares

The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells
por: Richardson, Kelden, et al.
Publicado: (2022)

Understanding the Role of T-Cells in the Antimyeloma Effect of Immunomodulatory Drugs
por: D'Souza, Criselle, et al.
Publicado: (2021)

PVRIG is a novel natural killer cell immune checkpoint receptor in acute myeloid leukemia
por: Li, Jessica, et al.
Publicado: (2020)

Chimeric Antigen Receptor beyond CAR-T Cells
por: Qin, Vicky Mengfei, et al.
Publicado: (2021)

BSBM-15 SYSTEMIC AND LOCAL IMMUNE RESPONSES FOLLOWING STEREOTACTIC RADIOSURGERY TO BRAIN METASTASES FROM HER2-AMPLIFIED BREAST CANCER
por: Sia, Joseph, et al.
Publicado: (2023)

CAR-T Plus Radiotherapy: A Promising Combination for Immunosuppressive Tumors
por: Qin, Vicky Mengfei, et al.
Publicado: (2022)

Combining chemotherapy with CAR-T cell therapy in treating solid tumors
por: Wang, Arthur Xuan, et al.
Publicado: (2023)

Enumeration, functional responses and cytotoxic capacity of MAIT cells in newly diagnosed and relapsed multiple myeloma
por: Gherardin, Nicholas A., et al.
Publicado: (2018)

Prognostically relevant natural killer cell-mediated immunoediting in acute myeloid leukemia
por: Chan, Christopher J, et al.
Publicado: (2013)

Immune molecular profiling of a multiresistant primary prostate cancer with a neuroendocrine-like phenotype: a case report
por: Williams, Scott G., et al.
Publicado: (2020)

Chimeric antigen receptor T cells form nonclassical and potent immune synapses driving rapid cytotoxicity
por: Davenport, A. J., et al.
Publicado: (2018)

Are the immuno-stimulatory properties of Lenalidomide extinguished by co-administration of Dexamethasone?
por: Hsu, Andy, et al.
Publicado: (2012)

Challenges of PD-L1 testing in non-small cell lung cancer and beyond
por: Wang, Minyu, et al.
Publicado: (2020)

Therapeutic strategies to remodel immunologically cold tumors
por: Wang, Minyu, et al.
Publicado: (2020)

Accumulation of CD103(+) CD8(+) T cells in a cutaneous melanoma micrometastasis
por: Hochheiser, Katharina, et al.
Publicado: (2019)

TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival
por: Freudenstein, Donald, et al.
Publicado: (2020)

Preclinical Evidence of the Efficacy of Lewis Y Car T Cells in Patient-Derived Models of Prostate Cancer
por: Risbridger, Gail Petuna, et al.
Publicado: (2021)

Consultor de enfermería obstétrica
por: Neeson, Jean D.
Publicado: (1995)

Consultor de enfermería obstétrica
por: Neeson, Jean D.
Publicado: (1989)

Innate immunity: Looking beyond T-cells in radiation and immunotherapy combinations
por: McMahon, R.A., et al.
Publicado: (2023)

Basic cancer immunology for radiation oncologists
por: Sia, Joseph, et al.
Publicado: (2022)

Improving the productivity and efficiency of vascular surgery and radiology multidisciplinary meetings
por: Dobson, Gary, et al.
Publicado: (2015)

Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma
por: Terry, Rachael L., et al.
Publicado: (2021)

Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer
por: Dushyanthen, Sathana, et al.
Publicado: (2017)

PROTOCOL: Psychosocial interventions for preventing PTSD in children exposed to war and conflict‐related violence: A systematic review
por: Hanratty, Jennifer, et al.
Publicado: (2019)

An Update on the Current Genomic Landscape of Breast Implant-Associated Anaplastic Large Cell Lymphoma
por: Harrop, Sean, et al.
Publicado: (2021)

High dose-rate brachytherapy of localized prostate cancer converts tumors from cold to hot
por: Keam, Simon P, et al.
Publicado: (2020)

Generating CAR T cells from tumor-infiltrating lymphocytes
por: Mills, Jane K., et al.
Publicado: (2021)

Enhancing the Potential of Immunotherapy in Paediatric Sarcomas: Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase Inhibitors
por: Fleuren, Emmy D. G., et al.
Publicado: (2021)

P1066: PEMBROLIZUMAB MONOTHERAPY AS A FIRST THERAPY FOR HODGKIN LYMPHOMA IS DELIVERABLE IN OLDER OR ABVD INELIGIBLE PATIENTS, DOES NOT PRECLUDE SUBSEQUENT THERAPY, AND PROVIDES ADEQUATE SURVIVAL.
por: Dickinson, Michael, et al.
Publicado: (2023)

CAR T cells take centre stage
por: Beavis, Paul A, et al.
Publicado: (2019)

P53: A Guardian of Immunity Becomes Its Saboteur through Mutation
por: Agupitan, Arjelle Decasa, et al.
Publicado: (2020)

Hotspots of species loss do not vary across future climate scenarios in a drought‐prone river basin
por: Gill, Kenneth C., et al.
Publicado: (2020)

Diesel exhaust particles modify natural killer cell function and cytokine release
por: Müller, Loretta, et al.
Publicado: (2013)

CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy
por: Giuffrida, Lauren, et al.
Publicado: (2021)

High‐dimensional analyses reveal a distinct role of T‐cell subsets in the immune microenvironment of gastric cancer
por: Wang, Minyu, et al.
Publicado: (2020)

Exhaust the exhausters: Targeting regulatory T cells in the tumor microenvironment
por: McRitchie, Bayley R., et al.
Publicado: (2022)

Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection
por: Sun, Joseph C., et al.
Publicado: (2011)

Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment
por: Pizzolla, Angela, et al.
Publicado: (2022)

Tissue‐specific tumor microenvironments influence responses to immunotherapies
por: Oliver, Amanda J, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gabca4fhenafojdg0dgqasgtr0